Detection of the T790M mutation is typically performed using methods such as liquid biopsy, which analyzes circulating tumor DNA (ctDNA) in the blood, or tissue biopsy, where a sample of the tumor is examined. Technologies like PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), and other molecular diagnostics are commonly employed for this purpose.
